TRAIL: Difference between revisions

Jump to navigation Jump to search
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
<StructureSection load='1d0g' size='340' side='right' caption='Human TRAIL trimer residues 114-281 (grey, light green, yellow) complex with death receptor-5 extracellular domain (dark blue, dark green, olive), Zn+2 (grey) and Cl-1 (green) ions, [[1d0g]]' scene=''>
<StructureSection load='1d0g' size='340' side='right' caption='Human TRAIL trimer residues 114-281 (grey, light green, yellow) complex with death receptor-5 extracellular domain (dark blue, dark green, olive), Zn+2 (grey) and Cl-1 (green) ions, [[1d0g]]' scene='' pspeed='8'>
== Function ==
== Function ==
'''TRAIL (TNF-related apoptosis-inducing ligand)''' functions as a ligand in the process of apoptosis<ref>PMID:15987601</ref>. TRAIL binds to death receptors DR4, DR5, DcR1 and DcR2.  For details see [[Molecular Playground/TRAIL]]. <scene name='48/480878/Cv/1'>TRAIL trimer residues complex with death receptor-5 extracellular domain</scene> ([[1d0g]]).  
'''TRAIL (TNF-related apoptosis-inducing ligand)''' or '''TNF ligand superfamily 10''' functions as a ligand in the process of apoptosis<ref>PMID:15987601</ref>. TRAIL binds to death receptors DR4, DR5, DcR1 and DcR2.  For details see [[Molecular Playground/TRAIL]]. '''TRAIL-R2''' is called '''DR5'''. <scene name='48/480878/Cv/3'>TRAIL trimer residues complex with death receptor-5 extracellular domain</scene> ([[1d0g]]). <scene name='48/480878/Cv/4'>Zn+2 and Cl-1 bind to 3 same Cys residues from different subunits of TRAIL trimer</scene>.
 
See also:
*[[Cytokine receptors]]
*[[Immune receptors]]


== Disease ==
== Disease ==
TRAIL concentrations are reduced in rheumatoid arithritis<ref>PMID:25962765</ref>.
TRAIL concentrations are reduced in rheumatoid arthritis<ref>PMID:25962765</ref>.
</StructureSection>
</StructureSection>
== 3D Structures of TRAIL ==
== 3D Structures of TRAIL ==
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
TRAIL-R2 domains – extracellular 54-184; transmembrane 208-242


[[1d0g]], [[1d4v]], [[1du3]] - hTRAIL residues 114-281 + DR5 extracellular domain - human<br />
[[1d0g]], [[1d4v]], [[1du3]], [[5cir]] - hTRAIL 114-281 + TRAIL-R2 extracellular domain - human<br />
[[1dg6]] – hTRAIL jelly-roll domain<br />
[[4n90]] - hTRAIL 114-281 + hTRAIL-R2 extracellular domain + antibody<br />
[[1d2q]] - hTRAIL extracellular domain
[[1dg6]] – hTRAIL jelly-roll domain 91-281<br />
[[1d2q]] - hTRAIL 114-281<br />
[[4i9x]] – hTRAIL-R2 extracellular domain + UL141<br />
[[3x3f]], [[1za3]], [[4od2]], [[2h9g]], [[6t3j]] – hTRAIL-R2 extracellular domain + antibody<br />
[[6nhw]] – hTRAIL-R2 transmembrane domain - NMR<br />
[[6nhy]] – hTRAIL-R2 transmembrane domain (mutant) - NMR<br />
== References ==
== References ==
<references/>
<references/>
[[Category:Topic Page]]
[[Category:Topic Page]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky